ID

21426

Description

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00289549

Link

https://clinicaltrials.gov/show/NCT00289549

Keywords

Versions (1)
  1. 4/21/17 4/21/17 -
Uploaded on

April 21, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia, Lymphocytic, Chronic NCT00289549

English

Eligibility Leukemia, Lymphocytic, Chronic NCT00289549

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
ages 18 years and older
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of cll established by peripheral blood and bone marrow examination and using the standard criteria
Description

Chronic Lymphocytic Leukemia | Blood--Examination Peripheral | Bone Marrow Examination | Criteria Standard

Data type

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2,1]
C3826648
UMLS CUI [2,2]
C0205100
UMLS CUI [3]
C0005957
UMLS CUI [4,1]
C0243161
UMLS CUI [4,2]
C1442989
patients with rai stage iii or iv, or earlier stage with massive, symptomatic lymphadenopathy requiring therapy
Description

Rai Staging System | Lymphadenopathy massive Symptomatic | Therapeutic procedure Patient need for

Data type

boolean

Alias
UMLS CUI [1]
C1514715
UMLS CUI [2,1]
C0235599
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0686904
primary resistance to fludarabine-based therapy (no complete response [cr] or partial response [pr]) or progressive disease within 6 months of response to prior fludarabine containing regimen.
Description

Therapeutic procedure Fludarabine Based | Resistance Primary | Complete response Absent | Partial response Absent | Progressive Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0059985
UMLS CUI [1,3]
C1705938
UMLS CUI [2,1]
C1514892
UMLS CUI [2,2]
C0205225
UMLS CUI [3,1]
C0677874
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C1521726
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C1335499
ecog performance status of 0, 1, 2 or 3
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
willing to take adequate contraception (i.e. latex condom, cervical cap, diaphragm, abstinence, etc.) for the entire duration of the study and 3 months after
Description

Contraceptive methods | Latex condom | CERVICAL CAP FOR CONTRACEPTIVE USE | Vaginal contraceptive diaphragm | Sexual Abstinence

Data type

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2]
C3873750
UMLS CUI [3]
C0493327
UMLS CUI [4]
C0042241
UMLS CUI [5]
C0036899
all investigational treatments should have been discontinued for at least 1 week prior to the initiation of the study drug.
Description

Investigational Therapies Discontinued

Data type

boolean

Alias
UMLS CUI [1,1]
C0949266
UMLS CUI [1,2]
C1444662
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
unable or unwilling to sign consent
Description

Informed Consent Unable | Informed Consent Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0558080
severe, ongoing co-morbid conditions, which would preclude safe delivery of the investigational therapy
Description

Comorbidity Severe | Investigational Therapy Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0949266
UMLS CUI [2,2]
C2828389
active serious infections that are not controlled by antibiotics
Description

Communicable Diseases Serious Uncontrolled | Antibiotics

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0205318
UMLS CUI [2]
C0003232
ecog performance status 4
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
inadequate renal function: creatinine 2.0 or more unless related to the disease
Description

Abnormal renal function | Creatinine measurement, serum | Serum creatinine measurement Disease Related

Data type

boolean

Alias
UMLS CUI [1]
C0151746
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0201976
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0439849
inadequate liver function: bilirubin 3.0 or more, transaminases 3 x upper limit of normal or more unless related to the disease
Description

Liver function abnormal | Serum total bilirubin measurement | Transaminases increased | Transaminases increased Disease Related

Data type

boolean

Alias
UMLS CUI [1]
C0151766
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0438717
UMLS CUI [4,1]
C0438717
UMLS CUI [4,2]
C0012634
UMLS CUI [4,3]
C0439849
known positive test for hiv
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
patients with known hepatitis b and/or hepatitis c active infection
Description

Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
Back to the top of the page

Similar models

Eligibility Leukemia, Lymphocytic, Chronic NCT00289549

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
ages 18 years and older
boolean
C0001779 (UMLS CUI [1])
Chronic Lymphocytic Leukemia | Blood--Examination Peripheral | Bone Marrow Examination | Criteria Standard
Item
diagnosis of cll established by peripheral blood and bone marrow examination and using the standard criteria
boolean
C0023434 (UMLS CUI [1])
C3826648 (UMLS CUI [2,1])
C0205100 (UMLS CUI [2,2])
C0005957 (UMLS CUI [3])
C0243161 (UMLS CUI [4,1])
C1442989 (UMLS CUI [4,2])
Rai Staging System | Lymphadenopathy massive Symptomatic | Therapeutic procedure Patient need for
Item
patients with rai stage iii or iv, or earlier stage with massive, symptomatic lymphadenopathy requiring therapy
boolean
C1514715 (UMLS CUI [1])
C0235599 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0087111 (UMLS CUI [3,1])
C0686904 (UMLS CUI [3,2])
Therapeutic procedure Fludarabine Based | Resistance Primary | Complete response Absent | Partial response Absent | Progressive Disease
Item
primary resistance to fludarabine-based therapy (no complete response [cr] or partial response [pr]) or progressive disease within 6 months of response to prior fludarabine containing regimen.
boolean
C0087111 (UMLS CUI [1,1])
C0059985 (UMLS CUI [1,2])
C1705938 (UMLS CUI [1,3])
C1514892 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C0677874 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1521726 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C1335499 (UMLS CUI [5])
ECOG performance status
Item
ecog performance status of 0, 1, 2 or 3
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods | Latex condom | CERVICAL CAP FOR CONTRACEPTIVE USE | Vaginal contraceptive diaphragm | Sexual Abstinence
Item
willing to take adequate contraception (i.e. latex condom, cervical cap, diaphragm, abstinence, etc.) for the entire duration of the study and 3 months after
boolean
C0700589 (UMLS CUI [1])
C3873750 (UMLS CUI [2])
C0493327 (UMLS CUI [3])
C0042241 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
Investigational Therapies Discontinued
Item
all investigational treatments should have been discontinued for at least 1 week prior to the initiation of the study drug.
boolean
C0949266 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Informed Consent Unable | Informed Consent Unwilling
Item
unable or unwilling to sign consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Comorbidity Severe | Investigational Therapy Excluded
Item
severe, ongoing co-morbid conditions, which would preclude safe delivery of the investigational therapy
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0949266 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Communicable Diseases Serious Uncontrolled | Antibiotics
Item
active serious infections that are not controlled by antibiotics
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0003232 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status 4
boolean
C1520224 (UMLS CUI [1])
Abnormal renal function | Creatinine measurement, serum | Serum creatinine measurement Disease Related
Item
inadequate renal function: creatinine 2.0 or more unless related to the disease
boolean
C0151746 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201976 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0439849 (UMLS CUI [3,3])
Liver function abnormal | Serum total bilirubin measurement | Transaminases increased | Transaminases increased Disease Related
Item
inadequate liver function: bilirubin 3.0 or more, transaminases 3 x upper limit of normal or more unless related to the disease
boolean
C0151766 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0438717 (UMLS CUI [3])
C0438717 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0439849 (UMLS CUI [4,3])
HIV Seropositivity
Item
known positive test for hiv
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
patients with known hepatitis b and/or hepatitis c active infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial